What do TNF proteins do?

Tumor necrosis factor (TNF α) is a proinflammatory cytokine that is mainly produced by macrophages and monocytes and participates in normal inflammatory response and immune responses. Tumor necrosis factor (TNF) is produced in many pathological conditions, including sepsis, malignant tumors, heart failure, and chronic inflammatory diseases. It usually exists in blood and body fluids in joints.

How does TNF affect the body?

TNF is a dense trimer composed of three identical monomer subunits. The effect of TNF on cells is mediated by cell surface receptors. The cytoplasmic tail region of the receptor contains a death domain (DD) or one or more TRAF interaction motifs (TIM). Taking death domain (DD) as an example, binding with ligands can recruit receptors containing death domain in cells, such as Fas-related death domain protein (FADD/MORT1) and TNF receptor-related death domain protein (TRADD), which together form the so-called death-inducing signaling complex (DISC). These molecules lead to caspase activation and apoptosis. TNF has a direct killing or inhibiting effect. TNF moves into cells after binding with corresponding receptors, and it is ingested by lysosome target cells leading to the decrease of lysosome stability, and the leakage of various enzymes leading to cell dissolution. It is also believed that TNF activates phospholipase A2 and releases superoxide to cause DNA breakage. Phospholipase A2 inhibitors can reduce the disease resistance effect of TNF. TNF can change the glucose metabolism of target cells, reduce the pH in cells, and cause cell death.

BlueGene Tumor Necrosis Factor Superfamily Proteins, TNF Superfamily Proteins

TNF Superfamily Proteins

TNF Superfamily tumor necrosis factor (TNF) is a proinflammatory cytokine secreted by immune cells. The TNF superfamily is generally composed of 19 TNF superfamily ligands (TNFSF) and 29 TNF receptor superfamily members (TNFRSF). TNFSF includes TNF- α, TNF- β, LT- β, CD27L, CD30L, CD40L, FasL, 4-1BBL, OX40L, TRAIL, LIGHT, RANKL, TWEAK, APRIL, BAFF, VEGI, EDA-A1, EDA-A2, GITRL.

TNFSF molecule is a trimeric type II transmembrane protein with the characteristics of conservative C-terminal TNF homologous domain (THD). TNF superfamily can induce apoptosis, proliferation, survival or differentiation of cells. The interaction between tumor necrosis factor ligand and its receptor mediates signal pathways that control the survival, proliferation, differentiation and effector functions of immune and non immune cells.

Products

Search ELISA Kits

TNF Superfamily Proteins Types

P01T0008 Human Tumor necrosis factor alpha (TNF-α) Protein, Recombinant
- Cat. No.: P01T0008
- Uniprot No.: P01375
- Expression Host: E.coli
- Expression Region: Met1-Leu233
- Fusion Tag:
P03T0008 Mouse Tumor Necrosis Factor α (TNF α) Protein, Recombinant
- Cat. No.: P03T0008
- Uniprot No.: P06804
- Expression Host: E.coli
- Expression Region: Leu 80-Leu 235
- Fusion Tag: 6×His-SUMO (N-terminus)

TNF Superfamily Proteins FAQs

Q
What do TNF proteins do?

Tumor necrosis factor (TNF α) is a proinflammatory cytokine that is mainly produced by macrophages and monocytes and participates in normal inflammatory response and immune responses. Tumor necrosis factor (TNF) is produced in many pathological conditions, including sepsis, malignant tumors, heart failure, and chronic inflammatory diseases. It usually exists in blood and body fluids in joints.
Q
How does TNF affect the body?

TNF is a dense trimer composed of three identical monomer subunits. The effect of TNF on cells is mediated by cell surface receptors. The cytoplasmic tail region of the receptor contains a death domain (DD) or one or more TRAF interaction motifs (TIM). Taking death domain (DD) as an example, binding with ligands can recruit receptors containing death domain in cells, such as Fas-related death domain protein (FADD/MORT1) and TNF receptor-related death domain protein (TRADD), which together form the so-called death-inducing signaling complex (DISC). These molecules lead to caspase activation and apoptosis. TNF has a direct killing or inhibiting effect. TNF moves into cells after binding with corresponding receptors, and it is ingested by lysosome target cells leading to the decrease of lysosome stability, and the leakage of various enzymes leading to cell dissolution. It is also believed that TNF activates phospholipase A2 and releases superoxide to cause DNA breakage. Phospholipase A2 inhibitors can reduce the disease resistance effect of TNF. TNF can change the glucose metabolism of target cells, reduce the pH in cells, and cause cell death.